Cytek 10-Q: Q3 Net Loss Widens to $6.1M; New ITC and Delaware Suits Filed Against Beckman Coulter
CTKB sits 80% above its 52-week low of $3.31.
Summary
Cytek's Q3 10-Q shows a $6.1 million quarterly net loss and $256.3 million in cash and securities, alongside newly disclosed ITC and Delaware patent suits against Beckman Coulter and no accrual for the $56.11 million jury verdict.
Key Events · Earnings and Guidance · CTKB
-
Q3 Loss Widens, Margins Improve
Revenue rose 2% to $53.2 million and GAAP gross margin reached 59% from 53%, but net loss widened to $6.1 million from $5.5 million a year earlier.
-
Nine-Month Loss Nearly Doubles
Net loss for the nine months ended September 30, 2026 was $37.1 million versus $22.5 million, driven by general and administrative expense up 26% to $53.7 million on litigation costs.
-
Cash Cushion Still Large
Cash, cash equivalents, restricted cash and marketable securities totaled $256.3 million at September 30, 2026, versus $261.5 million at December 31, 2025; management says this funds at least 12 months of operations.
-
Cytek Sues Beckman Coulter
On October 8, 2026 Cytek filed an ITC Section 337 complaint seeking an exclusion order on Beckman Coulter's mosaic 88 and mosaic 63 products, and on October 16, 2026 filed a Delaware suit seeking damages and injunctive relief.
Analysis · CTKB · Industrial Applications And Services
The headline numbers were already out, but the 10-Q carries two things the release did not: the full balance sheet and a fresh legal front. Cytek still holds $256.3 million in cash and securities against a $37.1 million nine-month operating loss, so funding is not the near-term issue. The bigger swing factor is the patent fight — Cytek lost one of four claims at the August jury trial with $56.11 million in damages awarded, has not accrued a liability because it judges loss only reasonably possible, and on October 8 and October 16 went on the offensive with an ITC complaint and a Delaware suit seeking an exclusion order and enhanced damages. General and administrative costs are already up 26% for the nine months on litigation spend, so the legal outcome, not the quarter's 2% revenue growth, is what moves the stock.
How filings like this one have moved
In the 30 days to Nov 17, 2026, 38% of the 3791 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, CTKB was trading at $5.97 on NASDAQ in the Industrial Applications And Services sector, with a market capitalization of approximately $764.3M. The 52-week trading range was $3.31 to $6.34. This filing was assessed with negative market sentiment and an importance score of 7 out of 10.